Cargando…

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice

Nonalcoholic fatty liver disease (NAFLD) is increasingly common among patients with type 2 diabetes mellitus (T2DM). The two conditions can act synergistically to produce adverse outcomes. However, the therapeutic options for patients with NAFLD and T2DM are currently limited. Human umbilical cord-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing, Cheng, Yu, Yu, Songyan, Zang, Li, Yin, Yaqi, Liu, Jiejie, Zhang, Lin, Mu, Yiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875176/ https://www.ncbi.nlm.nih.gov/pubmed/31781248 http://dx.doi.org/10.1155/2019/8628027

Ejemplares similares

Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
por: Gao, Jieqing, et al.
Publicado: (2019)

Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
por: Xue, Jing, et al.
Publicado: (2020)

Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes
por: Xue, Jing, et al.
Publicado: (2022)

Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
por: Yin, Yaqi, et al.
Publicado: (2018)

Human umbilical cord mesenchymal stem cells ameliorate acute liver failure by inhibiting apoptosis, inflammation and pyroptosis
por: Liu, Mengting, et al.
Publicado: (2021)

Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats
por: Sun, Xiaoya, et al.
Publicado: (2017)

Anti-obesity effect and mechanism of mesenchymal stem cells influence on obese mice
por: Xie, Zongyan, et al.
Publicado: (2021)

Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats
por: Yu, Songyan, et al.
Publicado: (2019)

Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial
por: Zang, Li, et al.
Publicado: (2022)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis
por: Yang, Fuji, et al.
Publicado: (2023)

Umbilical Cord Mesenchymal Stem Cells Ameliorate Premature Ovarian Insufficiency in Rats
por: Zhang, Meiliang, et al.
Publicado: (2022)

Amelioration of ligamentum flavum hypertrophy using umbilical cord mesenchymal stromal cell-derived extracellular vesicles
por: Ma, Cheng, et al.
Publicado: (2022)

Umbilical Cord Mesenchymal Stem Cells Ameliorate Inflammation-Related Tumorigenesis via Modulating Macrophages
por: Fu, Yanxia, et al.
Publicado: (2022)

Diabetic microenvironment preconditioning of adipose tissue-derived mesenchymal stem cells enhances their anti-diabetic, anti-long-term complications, and anti-inflammatory effects in type 2 diabetic rats
por: Su, Wanlu, et al.
Publicado: (2022)

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
por: Qian, Minyi, et al.
Publicado: (2019)

Human umbilical cord-derived mesenchymal stem cells ameliorate the enteropathy of food allergies in mice
por: Yan, Nannan, et al.
Publicado: (2018)

Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model
por: Chen, Lian, et al.
Publicado: (2020)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms
por: Yin, Fei, et al.
Publicado: (2019)

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
por: Liu, Yanying, et al.
Publicado: (2010)

Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota
por: Yang, Fan, et al.
Publicado: (2022)

Mesenchymal stem cell therapy in type 2 diabetes mellitus
por: Zang, Li, et al.
Publicado: (2017)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
por: Yang, Xiao-Fang, et al.
Publicado: (2021)

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice
por: Ding, Jian, et al.
Publicado: (2023)

Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses
por: Song, Ji-young, et al.
Publicado: (2019)

Dexmedetomidine ameliorates high‐fat diet‐induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice
por: Tao, Linfen, et al.
Publicado: (2020)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

Mesenchymal stem cells from human umbilical cord ameliorate testicular dysfunction in a male rat hypogonadism model
por: Zhang, Zhi-Yuan, et al.
Publicado: (2017)

The Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Mice Premature Ovarian Failure
por: Wang, Shufang, et al.
Publicado: (2013)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
por: Xiang, E, et al.
Publicado: (2020)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
por: Feng, Huan, et al.
Publicado: (2022)

KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
por: Jang, Ju-hong, et al.
Publicado: (2022)

Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury
por: Zhai, Xiao, et al.
Publicado: (2021)

The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Ndakotsu, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2bagvu9jdk9o64djv9h9qk6k1